S222 EFFECT OF STRONTIUM RANELATE ON VERTEBRAL PAIN SYNDROME AND FUNCTIONAL ABILITIES IN POSTMENOPAUSAL WOMEN WITH SYSTEMIC OSTEOPOROSIS

2011 ◽  
Vol 5 (S1) ◽  
pp. 229-229
Author(s):  
V. Povoroznyuk ◽  
N. Dzerovych ◽  
L. Bondarenco ◽  
V. Verych ◽  
A. Gnylorybov ◽  
...  
Keyword(s):  
Postmenopausal Women ◽  
Strontium Ranelate ◽  
Pain Syndrome ◽  
Functional Abilities

18 EFFECT OF STRONTIUM RANELATE ON VERTEBRAL PAIN SYNDROME AND FUNCTIONAL ABILITIES IN POSTMENOPAUSAL WOMEN WITH SYSTEMIC OSTEOPOROSIS

Maturitas ◽  
2012 ◽  
Vol 71 ◽  
pp. S22
Author(s):  
V. Povoroznyuk ◽  
N.I. Dzerovych ◽  
L.I. Bondarenco ◽  
V.F. Verych ◽  
A.M. Gnylorybov ◽  
...  
Keyword(s):  
Postmenopausal Women ◽  
Strontium Ranelate ◽  
Pain Syndrome ◽  
Functional Abilities

Effect of strontium ranelate on vertebral pain syndrome and functional abilities in postmenopausal women with systemic osteoporosis

Bone ◽  
2012 ◽  
Vol 50 ◽  
pp. S165
Author(s):  
V. Povoroznyuk⁎ ◽  
N. Dzerovych ◽  
L. Bondarenco ◽  
V. Verych ◽  
A. Gnylorybov ◽  
...  
Keyword(s):  
Postmenopausal Women ◽  
Strontium Ranelate ◽  
Pain Syndrome ◽  
Functional Abilities

AB1045 Effect of strontium ranelate on vertebral pain syndrome and functional abilities in women with glucocorticoid induced osteoporosis

2013 ◽  
Vol 71 (Suppl 3) ◽  
pp. 698.2-698
Author(s):  
V. Povoroznyuk ◽  
N.I. Dzerovych ◽  
L.I. Bondarenco ◽  
V.F. Verych ◽  
R.E. Gnylorybov ◽  
...  
Keyword(s):  
Strontium Ranelate ◽  
Pain Syndrome ◽  
Functional Abilities

scholarly journals Response to Comparison of Teriparatide and Strontium Ranelate in Postmenopausal Women With Osteoporosis

2009 ◽  
Vol 24 (12) ◽  
pp. 2067-2068 ◽  
Author(s):  
Robert R Recker ◽  
Sophia Ish-Shalom ◽  
Fernando Marín ◽  
Federico Hawkins ◽  
Jan Stepan
Keyword(s):  
Postmenopausal Women ◽  
Strontium Ranelate

scholarly journals Trajectories of Bone Remodeling Markers and Bone Mineral Density during Treatment with Strontium Ranelate in Postmenopausal Women Previously Treated with Bisphosphonates

2014 ◽  
Vol 7 ◽  
pp. CMED.S15086 ◽  
Author(s):  
Helisane Lima ◽  
Juliana Maia ◽  
Francisco Bandeira
Keyword(s):  
Bone Mineral Density ◽  
Lumbar Spine ◽  
Postmenopausal Women ◽  
Bone Mineral ◽  
Strontium Ranelate ◽  
Mineral Density ◽  
Bone Remodeling Markers ◽  
Before And After ◽  
Previously Treated

Objective To evaluate the responses of C-terminal telopeptide (CTX) and serum osteocalcin after the first 4 months of treatment with strontium ranelate (SR) and demonstrate their association with long-term bone density changes. Subjects and Methods A sample of 13 postmenopausal women with osteoporosis was analyzed (mean age 65 ± 7.7 years), who were treated with SR for an average of 2.56 ± 0.86 years. All patients had undergone previous treatment with bisphosphonates for an average period of 4.88 ± 2.27 years. Serum CTX and osteocalcin levels were determined before and after four months of treatment with SR. Bone mineral density in the lumbar spine and femoral neck were obtained before and after treatment with SR. Results We observed an average increase of 53.7% in the CTX levels, and 30.7% in the osteocalcin levels. The increase in bone markers was associated with a mean 4.8% increase in lumbar spine bone mineral density (BMD) from 0.820 to 0.860 g/cm2 ( T-score from –2.67 to –1.92; P= 0.001), after 2.5 years of treatment with SR. Conclusion These data suggest an anabolic effect of SR on postmenopausal women who were previously treated with long-term bisphosphonates.

Sign in / Sign up

Export Citation Format

Share Document